Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shugang Qin

Showing results (21-30 of 48) with videos related to

Pageof 5
Sort By:
Wiley Interdisciplinary Reviews. Nanomedicine and Nanobiotechnology|October 3, 2024
Insights into the formulation of lipid nanoparticles for the optimization of mRNA therapeuticsXiangyu Jiao, Xi He, Shugang Qin, et al.
Frontiers in Immunology|April 8, 2020
SHIP-1 Regulates Phagocytosis and M2 Polarization Through the PI3K/Akt-STAT5-Trib1 Circuit in <i>Pseudomonas aeruginosa</i> InfectionShugang Qin, Jiaxin Li, Chuanmin Zhou, et al.
Frontiers in Immunology|August 28, 2020
<i>oprC</i> Impairs Host Defense by Increasing the Quorum-Sensing-Mediated Virulence of <i>Pseudomonas aeruginosa</i>Pan Gao, Kai Guo, Qinqin Pu, et al.
Signal Transduction and Targeted Therapy|June 4, 2021
Bitter receptor TAS2R138 facilitates lipid droplet degradation in neutrophils during Pseudomonas aeruginosa infectionQinqin Pu, Kai Guo, Ping Lin, et al.
Journal of Leukocyte Biology|November 23, 2020
Annexin A2 regulates unfolded protein response via IRE1-XBP1 axis in macrophages during P. aeruginosa infectionChuan-Min Zhou, Li-Mei Luo, Ping Lin, et al.
Theranostics|June 23, 2021
Microbial and genetic-based framework identifies drug targets in inflammatory bowel diseaseZhihan Wang, Kai Guo, Pan Gao, et al.
Acta Biomaterialia|February 24, 2023
A cascade-responsive nanoplatform with tumor cell-specific drug burst release for chemotherapyXi He, Bei Xu, Aiping Fang, et al.
Signal Transduction and Targeted Therapy|May 21, 2022
mRNA-based therapeutics: powerful and versatile tools to combat diseasesShugang Qin, Xiaoshan Tang, Yuting Chen, et al.
Theranostics|January 29, 2026
Synergistic terahertz platforms for precision oncologyYan Chen, Xiaodan Kou, Jing Zou, et al.
Nucleic Acids Research|February 15, 2022
Type III CRISPR-based RNA editing for programmable control of SARS-CoV-2 and human coronavirusesPing Lin, Guanwang Shen, Kai Guo, et al.
Pageof 5

Showing results (21-30 of 48) with videos related to

Sort By:
Pageof 5
Wiley Interdisciplinary Reviews. Nanomedicine and Nanobiotechnology|October 3, 2024
Insights into the formulation of lipid nanoparticles for the optimization of mRNA therapeuticsXiangyu Jiao, Xi He, Shugang Qin, et al.
Frontiers in Immunology|April 8, 2020
SHIP-1 Regulates Phagocytosis and M2 Polarization Through the PI3K/Akt-STAT5-Trib1 Circuit in <i>Pseudomonas aeruginosa</i> InfectionShugang Qin, Jiaxin Li, Chuanmin Zhou, et al.
Frontiers in Immunology|August 28, 2020
<i>oprC</i> Impairs Host Defense by Increasing the Quorum-Sensing-Mediated Virulence of <i>Pseudomonas aeruginosa</i>Pan Gao, Kai Guo, Qinqin Pu, et al.
Signal Transduction and Targeted Therapy|June 4, 2021
Bitter receptor TAS2R138 facilitates lipid droplet degradation in neutrophils during Pseudomonas aeruginosa infectionQinqin Pu, Kai Guo, Ping Lin, et al.
Journal of Leukocyte Biology|November 23, 2020
Annexin A2 regulates unfolded protein response via IRE1-XBP1 axis in macrophages during P. aeruginosa infectionChuan-Min Zhou, Li-Mei Luo, Ping Lin, et al.
Theranostics|June 23, 2021
Microbial and genetic-based framework identifies drug targets in inflammatory bowel diseaseZhihan Wang, Kai Guo, Pan Gao, et al.
Acta Biomaterialia|February 24, 2023
A cascade-responsive nanoplatform with tumor cell-specific drug burst release for chemotherapyXi He, Bei Xu, Aiping Fang, et al.
Signal Transduction and Targeted Therapy|May 21, 2022
mRNA-based therapeutics: powerful and versatile tools to combat diseasesShugang Qin, Xiaoshan Tang, Yuting Chen, et al.
Theranostics|January 29, 2026
Synergistic terahertz platforms for precision oncologyYan Chen, Xiaodan Kou, Jing Zou, et al.
Nucleic Acids Research|February 15, 2022
Type III CRISPR-based RNA editing for programmable control of SARS-CoV-2 and human coronavirusesPing Lin, Guanwang Shen, Kai Guo, et al.
Pageof 5